Save time and jump to the most important pieces.
Date | Price Target | Rating | Analyst |
---|---|---|---|
1/25/2022 | $18.00 | Buy | Benchmark |
1/25/2022 | Buy | The Benchmark Company |
HONG KONG and TAIPEI, Taiwan, Sept. 16, 2021 /PRNewswire/ -- Gogoro® Inc. ("Gogoro" or the "Company"), a global technology leader in battery swapping ecosystems that enable sustainable mobility solutions for cities, and Poema Global Holdings Corp. (NASDAQ:PPGH, ", Poema Global", ))), a publicly traded special purpose acquisition company, today announced a definitive agreement for a business combination that would result in Gogoro becoming a publicly listed company. The combined company will focus on accelerating the global expansion of Gogoro's unique and proven subscription-based battery swapping service along with its electric vehicle and component sales business. Upon the transaction clos
Benchmark initiated coverage of Poema Global Hldgs with a rating of Buy and set a new price target of $18.00
The Benchmark Company initiated coverage of Poema Global Holdings Corp with a rating of Buy
15-15D - Poema Global Holdings Corp. (0001826333) (Filer)
25 - Poema Global Holdings Corp. (0001826333) (Filer)
8-K - Poema Global Holdings Corp. (0001826333) (Filer)
SC 13G/A - Poema Global Holdings Corp. (0001826333) (Subject)
SC 13G/A - Poema Global Holdings Corp. (0001826333) (Subject)
SC 13G/A - Poema Global Holdings Corp. (0001826333) (Subject)
Gainers GBS Inc. (NASDAQ:GBS) jumped 68% to settle at $1.31 on Monday. Zacks Small-Cap Research issued a note on GBS with an $8 valuation. Aterian, Inc. (NASDAQ:ATER) shares surged 46.8% to close at $3.42 on Monday. Aterian said Cynthia Williams has joined the Company's Board of Directors. Protalix BioTherapeutics, Inc. (NYSE:PLX) gained 41.9% to settle at $1.49. Protalix BioTherapeutics and Chiesi Global Rare Diseases, a unit of Chiesi Farmaceutici S.p.A., announced topline data from the BALANCE Phase 3 trial evaluating pegunigalsidase alfa (PRX–102) for Fabry disease. IO Biotech, Inc. (NASDAQ:IOBT) rose 33.2% to settle at $7.55. IO Biotech recently reported cash and equivalents of $
Poema Global Holdings Corp (NASDAQ:PPGH) shares are trading higher on above-average volume Monday following the completion of the company's business combination with EV battery swap solutions company Gogoro. Poema Global's average session volume over a 100-day period is about 138,000, according to data from Benzinga Pro. Monday's trading volume has already exceeded 5.5 million at publication time. The stock is seeing increased interest across social media platforms. It was among the top trending tickers on Stocktwits at last check. Gogoro is a global technology leader in battery swapping solutions. The company’s solutions provide a limitless range with battery swapping and can help cus
Merger to Deliver At Least $335M of Cash Proceeds to Support Gogoro's GrowthGogoro Expects to Close the Business Combination on April 4, 2022Gogoro Shares and Warrants Expected to Begin Trading on the Nasdaq on April 5 under Tickers "GGR" and "GGROW", respectivelyTAIPEI, Taiwan and HONG KONG, March 31, 2022 /PRNewswire/ -- Gogoro® Inc. ("Gogoro" or the "Company"), the global technology leader in battery swapping ecosystems that enable sustainable mobility solutions for cities, and Poema Global Holdings Corp. (NASDAQ:PPGH, ", Poema Global", ))), a publicly traded, special purpose acquisition company, today announced that their previously announced business combination (the "Business Combinati
Business Combination of Gogoro and Poema Global Expected to be Approved by ShareholdersMerger to Deliver At Least $335M of Cash Proceeds to Gogoro to Support GrowthGogoro Expects to Close the Transaction on April 4, 2022TAIPEI, Taiwan, March 30, 2022 /PRNewswire/ -- Gogoro® Inc. ("Gogoro" or the "Company"), a global technology leader in battery swapping ecosystems that enable sustainable mobility solutions for cities, today announced it expects to close its business combination transaction with Poema Global Holdings Corp. ("Poema Global") (NASDAQ:PPGH) on April 4, following anticipated shareholder approval on March 31. The transaction is expected to provide at least $335M of gross proceeds t
Gogoro's unaudited 2021 revenue exceeded prior projected 2021 revenue by approximately 10%.Gogoro increases PIPE to $295M.Gogoro expects to close its business combination transaction with Poema Global in early April and list on the Nasdaq under the symbol "GGR."TAIPEI, Taiwan, March 21, 2022 /PRNewswire/ -- Gogoro® Inc. ("Gogoro" or the "Company"), a global technology leader in battery swapping ecosystems that enable sustainable mobility solutions for cities, today announced an update to its unaudited 2021 revenue and an increase to its PIPE to $295M. Gogoro is in a strong position to fund its business plan and is committed to closing its SPAC transaction with Poema Global Holdings Corp. ("P